Heart Failure

High-sensitivity troponin assays need careful interpretation

02/03/2010 | High-sensitivity assays for troponin will assist the very early diagnosis and treatment of acute coronary syndromes but will also require clinicians to carefully interpret the results in every patient.


Warfarin can be stopped 3-6 months post ablation

23/02/2010 | It is safe to stop oral anticoagulation therapy after three to six months in patients who undergo catheter ablation of atrial fibrillation, a non-randomised study suggests.


More evidence ARBS are neuroprotective

23/02/2010 | Experimental data suggesting angiotensin receptor blockers may prevent against stroke has been strengthened after a study found pre-stroke treatment with ARBs may reduce severity and improve outcomes after stroke.


Pre-op stress testing improves surgery outcomes

03/02/2010 | Preoperative non-invasive cardiac stress testing improves one-year survival and reduces hospital stay in patients undergoing intermediate to high-risk non-cardiac surgery, a large retrospective study finds.


Stay alert for heart failure despite normal echo

20/01/2010 | Data from patients admitted to Royal Adelaide Hospital have re-emphasised the need to recognise the likelihood of heart failure in patients who have typical symptoms but normal left ventricular size and function.


Omega-3 fatty acids protects against cellular aging

20/01/2010 | New research recently published in JAMA suggests omega-3 fatty acids may protect against cellular aging in patients with coronary heart disease.


Careful selection of antithrombotic drugs vital

16/12/2009 | Antithrombotic drug combinations in patients with MI should be carefully individualised to avoid excessive bleeding risk, experts say.


BNP testing little help in acute heart failure

02/12/2009 | History and examination remain the gold standard for diagnosing heart failure in the acute setting, with B-type Natriuretic Peptide testing offering little extra in either specificity or sensitivity, Australian research shows.


Iron deficiency a new therapeutic target in heart failure?

18/11/2009 | Treatment with intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency, with or without anaemia, improves symptoms, functional capacity, and quality of life, the FAIR-HF study has found.


Higher losartan doses best in HF

18/11/2009 | Higher doses of losartan may improve clinical outcomes in some patients with heart failure, new research indicates


More Heart Failure news

Journals

Members of Cardiology Update can access the following journals for free:

Recent comments

Most viewed articles this week

Related sites